Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Obsessive-Compulsive Disorder | 103 | 2024 | 1489 | 14.220 |
Why?
|
Cycloserine | 7 | 2019 | 118 | 2.060 |
Why?
|
Tourette Syndrome | 16 | 2023 | 394 | 1.620 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 21 | 2023 | 3701 | 1.350 |
Why?
|
Psychiatric Status Rating Scales | 39 | 2024 | 6015 | 1.290 |
Why?
|
Implosive Therapy | 5 | 2021 | 124 | 1.280 |
Why?
|
Tic Disorders | 5 | 2023 | 136 | 1.100 |
Why?
|
Extinction, Psychological | 3 | 2019 | 371 | 1.070 |
Why?
|
Fear | 4 | 2019 | 1462 | 1.050 |
Why?
|
Comorbidity | 33 | 2024 | 10553 | 0.920 |
Why?
|
Child | 96 | 2024 | 79799 | 0.870 |
Why?
|
Adolescent | 89 | 2024 | 87809 | 0.760 |
Why?
|
Trichotillomania | 1 | 2023 | 177 | 0.740 |
Why?
|
Sensation Disorders | 2 | 2014 | 160 | 0.720 |
Why?
|
Anxiety Disorders | 13 | 2023 | 2714 | 0.710 |
Why?
|
Endophenotypes | 2 | 2021 | 255 | 0.680 |
Why?
|
Hand-Assisted Laparoscopy | 1 | 2019 | 16 | 0.680 |
Why?
|
Executive Function | 3 | 2017 | 1374 | 0.680 |
Why?
|
Phobic Disorders | 3 | 2019 | 437 | 0.630 |
Why?
|
Antimetabolites | 1 | 2018 | 128 | 0.600 |
Why?
|
Siblings | 1 | 2021 | 824 | 0.550 |
Why?
|
Combined Modality Therapy | 11 | 2024 | 8552 | 0.540 |
Why?
|
Hepatectomy | 1 | 2019 | 559 | 0.520 |
Why?
|
Age of Onset | 17 | 2017 | 3302 | 0.500 |
Why?
|
Cognition Disorders | 3 | 2021 | 3976 | 0.500 |
Why?
|
Psychometrics | 14 | 2022 | 3051 | 0.500 |
Why?
|
Severity of Illness Index | 30 | 2024 | 15840 | 0.490 |
Why?
|
Sensation | 2 | 2014 | 331 | 0.470 |
Why?
|
Obsessive Behavior | 5 | 2018 | 51 | 0.470 |
Why?
|
Personality Assessment | 5 | 2021 | 650 | 0.450 |
Why?
|
Neurobiology | 1 | 2014 | 137 | 0.430 |
Why?
|
Paroxetine | 2 | 2004 | 182 | 0.430 |
Why?
|
Propylamines | 3 | 2007 | 161 | 0.420 |
Why?
|
Parents | 5 | 2021 | 3549 | 0.410 |
Why?
|
Adrenergic Uptake Inhibitors | 3 | 2007 | 186 | 0.400 |
Why?
|
Family | 10 | 2023 | 3189 | 0.370 |
Why?
|
Psychomotor Performance | 2 | 2017 | 1878 | 0.350 |
Why?
|
Humans | 133 | 2024 | 760613 | 0.350 |
Why?
|
Behavioral Symptoms | 1 | 2012 | 185 | 0.350 |
Why?
|
Neuropsychological Tests | 4 | 2021 | 7022 | 0.340 |
Why?
|
Male | 89 | 2024 | 359718 | 0.340 |
Why?
|
Child Behavior Disorders | 4 | 2017 | 805 | 0.330 |
Why?
|
Occupational Therapy | 2 | 2023 | 139 | 0.310 |
Why?
|
Female | 84 | 2024 | 391246 | 0.300 |
Why?
|
Personality Inventory | 3 | 2021 | 1018 | 0.290 |
Why?
|
Compulsive Behavior | 3 | 2013 | 117 | 0.280 |
Why?
|
Depression | 5 | 2017 | 8045 | 0.270 |
Why?
|
Liver Neoplasms | 3 | 2019 | 4319 | 0.260 |
Why?
|
Perinatal Care | 1 | 2008 | 242 | 0.260 |
Why?
|
Life Change Events | 1 | 2010 | 952 | 0.250 |
Why?
|
Treatment Outcome | 26 | 2024 | 64981 | 0.250 |
Why?
|
Standard of Care | 2 | 2020 | 552 | 0.240 |
Why?
|
Fluoxetine | 2 | 2001 | 733 | 0.240 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 7 | 2017 | 1988 | 0.220 |
Why?
|
Awareness | 3 | 2018 | 646 | 0.210 |
Why?
|
Double-Blind Method | 10 | 2019 | 12427 | 0.210 |
Why?
|
Quantitative Trait, Heritable | 2 | 2017 | 540 | 0.210 |
Why?
|
Conduct Disorder | 1 | 2024 | 245 | 0.200 |
Why?
|
Adolescent Behavior | 2 | 2004 | 1175 | 0.190 |
Why?
|
Family Health | 3 | 2014 | 1257 | 0.190 |
Why?
|
Sertraline | 2 | 1999 | 208 | 0.190 |
Why?
|
Stroop Test | 1 | 2021 | 71 | 0.190 |
Why?
|
Desipramine | 2 | 2002 | 182 | 0.180 |
Why?
|
Family Relations | 3 | 2019 | 318 | 0.180 |
Why?
|
Mood Disorders | 3 | 2024 | 1124 | 0.180 |
Why?
|
Genetic Predisposition to Disease | 9 | 2021 | 17790 | 0.170 |
Why?
|
Educational Status | 2 | 2024 | 2514 | 0.170 |
Why?
|
Self Report | 4 | 2019 | 3711 | 0.170 |
Why?
|
Dysgammaglobulinemia | 1 | 2019 | 21 | 0.170 |
Why?
|
Antidepressive Agents | 4 | 2019 | 2890 | 0.170 |
Why?
|
Models, Psychological | 2 | 2015 | 827 | 0.160 |
Why?
|
Societies, Scientific | 1 | 2020 | 221 | 0.160 |
Why?
|
Anxiety | 5 | 2022 | 4538 | 0.160 |
Why?
|
Child Behavior | 1 | 2004 | 847 | 0.150 |
Why?
|
Cost of Illness | 2 | 2019 | 1940 | 0.150 |
Why?
|
Adolescent Health Services | 1 | 2000 | 218 | 0.150 |
Why?
|
Adult | 36 | 2023 | 220007 | 0.150 |
Why?
|
Stress Disorders, Post-Traumatic | 2 | 2017 | 4555 | 0.150 |
Why?
|
Interview, Psychological | 4 | 2011 | 810 | 0.140 |
Why?
|
Human Development | 1 | 1998 | 123 | 0.140 |
Why?
|
Tics | 3 | 2004 | 73 | 0.140 |
Why?
|
Excitatory Amino Acid Agonists | 1 | 2017 | 143 | 0.140 |
Why?
|
Pregnancy Complications | 3 | 2008 | 2942 | 0.140 |
Why?
|
N-Methylaspartate | 1 | 2017 | 231 | 0.140 |
Why?
|
Social Behavior Disorders | 1 | 1996 | 96 | 0.140 |
Why?
|
Emotions | 4 | 2021 | 2734 | 0.140 |
Why?
|
Bipolar Disorder | 3 | 2010 | 5078 | 0.130 |
Why?
|
Conditioning, Classical | 1 | 2019 | 364 | 0.130 |
Why?
|
Autoimmune Diseases | 2 | 2019 | 2250 | 0.130 |
Why?
|
Family Therapy | 1 | 2017 | 213 | 0.130 |
Why?
|
Quality of Life | 1 | 2017 | 13308 | 0.130 |
Why?
|
Problem Solving | 1 | 2018 | 440 | 0.130 |
Why?
|
Immunoglobulin A | 1 | 2019 | 978 | 0.130 |
Why?
|
Perception | 2 | 2014 | 1195 | 0.120 |
Why?
|
Blood Loss, Surgical | 1 | 2019 | 656 | 0.120 |
Why?
|
Neurotransmitter Agents | 1 | 2019 | 663 | 0.120 |
Why?
|
Behavior Therapy | 2 | 2017 | 868 | 0.120 |
Why?
|
Rehabilitation, Vocational | 1 | 2015 | 81 | 0.120 |
Why?
|
Placebos | 4 | 2004 | 1668 | 0.120 |
Why?
|
Reproducibility of Results | 9 | 2022 | 20080 | 0.120 |
Why?
|
Factor Analysis, Statistical | 3 | 2021 | 998 | 0.120 |
Why?
|
Radiology, Interventional | 1 | 1998 | 475 | 0.120 |
Why?
|
Child Health Services | 1 | 2000 | 644 | 0.120 |
Why?
|
Object Attachment | 1 | 2016 | 324 | 0.110 |
Why?
|
Case-Control Studies | 9 | 2021 | 22052 | 0.110 |
Why?
|
Tumor Burden | 1 | 2019 | 1895 | 0.110 |
Why?
|
Immunomodulation | 1 | 2017 | 547 | 0.110 |
Why?
|
Biopsy, Needle | 1 | 1998 | 1630 | 0.110 |
Why?
|
Multifactorial Inheritance | 2 | 2019 | 1365 | 0.100 |
Why?
|
Streptococcal Infections | 1 | 2017 | 617 | 0.100 |
Why?
|
Internationality | 1 | 2018 | 1004 | 0.100 |
Why?
|
Blood Transfusion | 1 | 2019 | 1328 | 0.100 |
Why?
|
Sex Factors | 8 | 2019 | 10546 | 0.100 |
Why?
|
Magnetoencephalography | 2 | 2007 | 634 | 0.100 |
Why?
|
Prevalence | 7 | 2019 | 15686 | 0.100 |
Why?
|
Age Factors | 11 | 2019 | 18413 | 0.100 |
Why?
|
Propensity Score | 1 | 2019 | 1926 | 0.100 |
Why?
|
Genetic Linkage | 2 | 2014 | 2381 | 0.100 |
Why?
|
Excitatory Amino Acid Transporter 3 | 1 | 2011 | 32 | 0.100 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 1 | 2016 | 893 | 0.090 |
Why?
|
Anxiety, Separation | 1 | 2011 | 86 | 0.090 |
Why?
|
Genome-Wide Association Study | 8 | 2019 | 12628 | 0.090 |
Why?
|
Mobility Limitation | 1 | 2015 | 402 | 0.090 |
Why?
|
Dopamine Uptake Inhibitors | 1 | 2012 | 297 | 0.090 |
Why?
|
Parenting | 1 | 2016 | 695 | 0.090 |
Why?
|
Genes, Homeobox | 1 | 2011 | 284 | 0.090 |
Why?
|
Depressive Disorder, Major | 3 | 2017 | 4744 | 0.090 |
Why?
|
Evidence-Based Practice | 1 | 2015 | 496 | 0.090 |
Why?
|
Chi-Square Distribution | 4 | 2009 | 3465 | 0.090 |
Why?
|
Polymorphism, Single Nucleotide | 8 | 2017 | 15790 | 0.090 |
Why?
|
Interviews as Topic | 1 | 2017 | 2659 | 0.090 |
Why?
|
DNA Copy Number Variations | 2 | 2019 | 2013 | 0.090 |
Why?
|
Memory, Short-Term | 2 | 2007 | 978 | 0.080 |
Why?
|
Consensus | 1 | 2019 | 3113 | 0.080 |
Why?
|
Risk Factors | 11 | 2017 | 74333 | 0.080 |
Why?
|
Depressive Disorder | 2 | 1999 | 3726 | 0.080 |
Why?
|
Mental Disorders | 8 | 2019 | 6796 | 0.080 |
Why?
|
Psychological Tests | 1 | 2011 | 639 | 0.080 |
Why?
|
Sensory Gating | 1 | 2008 | 47 | 0.080 |
Why?
|
Glutamic Acid | 1 | 2014 | 1167 | 0.080 |
Why?
|
Perinatology | 1 | 2008 | 62 | 0.080 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2016 | 10826 | 0.080 |
Why?
|
Amygdala | 1 | 2016 | 1351 | 0.080 |
Why?
|
Rheumatic Fever | 1 | 2008 | 75 | 0.080 |
Why?
|
Evidence-Based Medicine | 1 | 2020 | 3696 | 0.080 |
Why?
|
Methylphenidate | 1 | 2012 | 488 | 0.080 |
Why?
|
Young Adult | 11 | 2019 | 58748 | 0.080 |
Why?
|
Environment | 1 | 2014 | 1118 | 0.080 |
Why?
|
Visual Perception | 2 | 2007 | 1374 | 0.070 |
Why?
|
Referral and Consultation | 2 | 2000 | 3598 | 0.070 |
Why?
|
Body Weight | 2 | 2016 | 4611 | 0.070 |
Why?
|
Alpha Rhythm | 1 | 2007 | 109 | 0.070 |
Why?
|
Caregivers | 1 | 2019 | 2224 | 0.070 |
Why?
|
Brain | 1 | 2014 | 26951 | 0.070 |
Why?
|
Antidepressive Agents, Tricyclic | 2 | 2002 | 432 | 0.070 |
Why?
|
Dopamine | 1 | 2014 | 1595 | 0.070 |
Why?
|
Cognition | 3 | 2021 | 6964 | 0.070 |
Why?
|
Boston | 3 | 2016 | 9278 | 0.070 |
Why?
|
Interpersonal Relations | 1 | 2014 | 1428 | 0.070 |
Why?
|
Antimanic Agents | 1 | 2010 | 520 | 0.070 |
Why?
|
Cross-Sectional Studies | 5 | 2021 | 25941 | 0.070 |
Why?
|
Sex Characteristics | 2 | 2016 | 2629 | 0.060 |
Why?
|
Growth | 1 | 2007 | 365 | 0.060 |
Why?
|
Phenotype | 5 | 2013 | 16548 | 0.060 |
Why?
|
Indans | 1 | 2006 | 91 | 0.060 |
Why?
|
Length of Stay | 1 | 2019 | 6476 | 0.060 |
Why?
|
Middle Aged | 17 | 2019 | 220359 | 0.060 |
Why?
|
Nitric Oxide Synthase | 2 | 1998 | 908 | 0.060 |
Why?
|
Societies, Medical | 1 | 2016 | 3905 | 0.060 |
Why?
|
Cholinesterase Inhibitors | 1 | 2006 | 238 | 0.060 |
Why?
|
Clomipramine | 1 | 2003 | 54 | 0.060 |
Why?
|
Practice Guidelines as Topic | 2 | 2023 | 7475 | 0.060 |
Why?
|
Benzodiazepines | 1 | 2010 | 1131 | 0.060 |
Why?
|
Massachusetts | 3 | 2004 | 8803 | 0.060 |
Why?
|
Child of Impaired Parents | 1 | 2007 | 459 | 0.050 |
Why?
|
Tumor Suppressor Protein p53 | 3 | 1998 | 2924 | 0.050 |
Why?
|
Pediatrics | 2 | 2015 | 3586 | 0.050 |
Why?
|
Aged | 13 | 2019 | 169143 | 0.050 |
Why?
|
Arousal | 1 | 2008 | 1157 | 0.050 |
Why?
|
Communication | 2 | 2014 | 3849 | 0.050 |
Why?
|
Sampling Studies | 1 | 2003 | 613 | 0.050 |
Why?
|
Social Participation | 1 | 2023 | 183 | 0.050 |
Why?
|
Drug Interactions | 1 | 2006 | 1428 | 0.050 |
Why?
|
Diagnosis, Differential | 3 | 2002 | 12968 | 0.050 |
Why?
|
Stroke | 1 | 2023 | 9952 | 0.050 |
Why?
|
Child Development Disorders, Pervasive | 1 | 2006 | 599 | 0.050 |
Why?
|
Odds Ratio | 2 | 2010 | 9716 | 0.050 |
Why?
|
Consumer Product Safety | 1 | 2001 | 123 | 0.050 |
Why?
|
Least-Squares Analysis | 1 | 2001 | 369 | 0.050 |
Why?
|
Linear Models | 1 | 2010 | 5877 | 0.040 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2010 | 10343 | 0.040 |
Why?
|
Observer Variation | 1 | 2006 | 2601 | 0.040 |
Why?
|
Drug Monitoring | 1 | 2006 | 965 | 0.040 |
Why?
|
Reward | 1 | 2006 | 963 | 0.040 |
Why?
|
Statistics as Topic | 1 | 2005 | 2362 | 0.040 |
Why?
|
Hydrocephalus, Normal Pressure | 1 | 1979 | 99 | 0.040 |
Why?
|
Research | 1 | 2007 | 1974 | 0.040 |
Why?
|
Cerebrospinal Fluid Shunts | 1 | 1979 | 195 | 0.040 |
Why?
|
Twins | 1 | 2019 | 339 | 0.040 |
Why?
|
Attention | 1 | 2008 | 2387 | 0.040 |
Why?
|
Time Factors | 2 | 2017 | 40139 | 0.040 |
Why?
|
Compulsive Personality Disorder | 1 | 2017 | 48 | 0.040 |
Why?
|
Piperidines | 1 | 2006 | 1650 | 0.040 |
Why?
|
Sex Distribution | 2 | 2001 | 2294 | 0.040 |
Why?
|
Smoking | 1 | 2014 | 9073 | 0.040 |
Why?
|
Psychotherapy | 1 | 2006 | 1640 | 0.040 |
Why?
|
Cooperative Behavior | 2 | 2014 | 1500 | 0.030 |
Why?
|
Administration, Oral | 1 | 2004 | 4035 | 0.030 |
Why?
|
British Columbia | 1 | 2016 | 240 | 0.030 |
Why?
|
Clinical Trials as Topic | 2 | 2006 | 8055 | 0.030 |
Why?
|
Endothelial Growth Factors | 1 | 1998 | 673 | 0.030 |
Why?
|
Wechsler Scales | 1 | 1996 | 257 | 0.030 |
Why?
|
Social Adjustment | 1 | 1998 | 632 | 0.030 |
Why?
|
Laboratory Infection | 1 | 1995 | 7 | 0.030 |
Why?
|
Hemorrhagic Fever, American | 1 | 1995 | 12 | 0.030 |
Why?
|
Lymphokines | 1 | 1998 | 927 | 0.030 |
Why?
|
Arenaviruses, New World | 1 | 1995 | 35 | 0.030 |
Why?
|
Predictive Value of Tests | 4 | 2006 | 15286 | 0.030 |
Why?
|
Follow-Up Studies | 6 | 2014 | 39262 | 0.030 |
Why?
|
Child, Preschool | 7 | 2017 | 42056 | 0.030 |
Why?
|
Suicide | 1 | 2006 | 1599 | 0.030 |
Why?
|
Receptor-Like Protein Tyrosine Phosphatases, Class 2 | 1 | 2014 | 21 | 0.030 |
Why?
|
Pregnancy | 3 | 2008 | 29746 | 0.030 |
Why?
|
Activities of Daily Living | 1 | 2023 | 2417 | 0.030 |
Why?
|
Drug Administration Schedule | 2 | 2006 | 4899 | 0.030 |
Why?
|
Recurrence | 2 | 2004 | 8483 | 0.030 |
Why?
|
Ribavirin | 1 | 1995 | 396 | 0.030 |
Why?
|
Neoplasms, Experimental | 1 | 1998 | 1229 | 0.030 |
Why?
|
Drug Synergism | 1 | 2017 | 1752 | 0.030 |
Why?
|
Hydrocephalus | 1 | 1979 | 763 | 0.030 |
Why?
|
Analysis of Variance | 1 | 2001 | 6238 | 0.030 |
Why?
|
Age Distribution | 1 | 1998 | 2893 | 0.030 |
Why?
|
Personality Disorders | 1 | 2017 | 721 | 0.030 |
Why?
|
Chromosomes, Human, Pair 9 | 1 | 2014 | 534 | 0.030 |
Why?
|
Mutation, Missense | 1 | 2021 | 2567 | 0.020 |
Why?
|
Social Class | 2 | 2001 | 2005 | 0.020 |
Why?
|
Benchmarking | 1 | 2018 | 1044 | 0.020 |
Why?
|
Dependent Personality Disorder | 1 | 2011 | 13 | 0.020 |
Why?
|
Parietal Lobe | 2 | 2007 | 850 | 0.020 |
Why?
|
Signal Transduction | 1 | 2014 | 23374 | 0.020 |
Why?
|
Syndrome | 1 | 2017 | 3280 | 0.020 |
Why?
|
Celiac Disease | 1 | 2019 | 822 | 0.020 |
Why?
|
Agoraphobia | 1 | 2011 | 177 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2006 | 14661 | 0.020 |
Why?
|
Aged, 80 and over | 5 | 2017 | 58980 | 0.020 |
Why?
|
Databases, Genetic | 1 | 2017 | 1738 | 0.020 |
Why?
|
Chromosomes, Human, Pair 15 | 1 | 2011 | 363 | 0.020 |
Why?
|
Equipment Design | 1 | 1998 | 3520 | 0.020 |
Why?
|
Mass Screening | 1 | 2006 | 5422 | 0.020 |
Why?
|
Genetic Association Studies | 1 | 2019 | 2716 | 0.020 |
Why?
|
Linkage Disequilibrium | 1 | 2015 | 1996 | 0.020 |
Why?
|
Liver | 3 | 1997 | 7510 | 0.020 |
Why?
|
Brazil | 2 | 2009 | 1212 | 0.020 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2011 | 635 | 0.020 |
Why?
|
Neoplasms | 1 | 1998 | 22075 | 0.020 |
Why?
|
Demography | 1 | 2014 | 1650 | 0.020 |
Why?
|
Perioperative Period | 1 | 2010 | 264 | 0.020 |
Why?
|
Central Nervous System Stimulants | 2 | 2012 | 1174 | 0.020 |
Why?
|
Delayed-Action Preparations | 1 | 2012 | 961 | 0.020 |
Why?
|
Hemodynamics | 1 | 1999 | 4173 | 0.020 |
Why?
|
Cholic Acids | 1 | 1988 | 39 | 0.020 |
Why?
|
Postoperative Complications | 1 | 2010 | 15679 | 0.020 |
Why?
|
Genotype | 2 | 2014 | 12957 | 0.020 |
Why?
|
Trans-Activators | 1 | 1997 | 2860 | 0.020 |
Why?
|
Infection Control | 1 | 1995 | 983 | 0.020 |
Why?
|
Prospective Studies | 5 | 2019 | 54306 | 0.020 |
Why?
|
Regression Analysis | 2 | 2009 | 6359 | 0.020 |
Why?
|
Cortical Synchronization | 1 | 2007 | 77 | 0.020 |
Why?
|
Self-Assessment | 1 | 2009 | 393 | 0.020 |
Why?
|
Panic Disorder | 1 | 2011 | 613 | 0.020 |
Why?
|
Cohort Studies | 2 | 2021 | 41337 | 0.020 |
Why?
|
Radiography | 1 | 1998 | 6965 | 0.020 |
Why?
|
Patient Care Team | 1 | 1998 | 2511 | 0.020 |
Why?
|
Nitric Oxide | 1 | 1996 | 2141 | 0.020 |
Why?
|
Gene Frequency | 1 | 2013 | 3613 | 0.020 |
Why?
|
Acute Disease | 1 | 2017 | 7268 | 0.020 |
Why?
|
Disease Management | 1 | 2017 | 2514 | 0.020 |
Why?
|
Logistic Models | 1 | 2001 | 13312 | 0.020 |
Why?
|
Occipital Lobe | 1 | 2007 | 373 | 0.020 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2014 | 3774 | 0.020 |
Why?
|
Prefrontal Cortex | 2 | 2007 | 2212 | 0.020 |
Why?
|
Research Design | 1 | 2021 | 6180 | 0.020 |
Why?
|
Retrospective Studies | 6 | 2019 | 80345 | 0.020 |
Why?
|
Ambulatory Care | 1 | 1996 | 2782 | 0.020 |
Why?
|
Genetic Markers | 1 | 2011 | 2609 | 0.020 |
Why?
|
Patch-Clamp Techniques | 1 | 2007 | 932 | 0.020 |
Why?
|
Apoptosis | 2 | 1998 | 9497 | 0.020 |
Why?
|
Risk Assessment | 1 | 2006 | 24102 | 0.020 |
Why?
|
Haplotypes | 1 | 2011 | 2764 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 1999 | 11152 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 1995 | 6498 | 0.010 |
Why?
|
Disease Susceptibility | 1 | 2011 | 1792 | 0.010 |
Why?
|
Models, Genetic | 1 | 2014 | 3442 | 0.010 |
Why?
|
Universities | 1 | 2009 | 992 | 0.010 |
Why?
|
Principal Component Analysis | 1 | 2006 | 939 | 0.010 |
Why?
|
Aggression | 1 | 2006 | 745 | 0.010 |
Why?
|
Adenocarcinoma | 1 | 1999 | 6316 | 0.010 |
Why?
|
Evoked Potentials | 1 | 2007 | 1036 | 0.010 |
Why?
|
Reaction Time | 1 | 2007 | 2075 | 0.010 |
Why?
|
Body Height | 1 | 2007 | 1570 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2019 | 18137 | 0.010 |
Why?
|
Prognosis | 3 | 2009 | 29661 | 0.010 |
Why?
|
Genetic Variation | 1 | 2015 | 6552 | 0.010 |
Why?
|
Tumor Cells, Cultured | 2 | 1998 | 6130 | 0.010 |
Why?
|
Colorectal Neoplasms | 1 | 1999 | 6853 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2007 | 36286 | 0.010 |
Why?
|
Life Tables | 1 | 1999 | 365 | 0.010 |
Why?
|
Social Behavior | 1 | 2006 | 1131 | 0.010 |
Why?
|
Cell Nucleus | 1 | 1988 | 2907 | 0.010 |
Why?
|
Haloperidol | 1 | 2000 | 389 | 0.010 |
Why?
|
Attention Deficit and Disruptive Behavior Disorders | 1 | 2000 | 306 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2014 | 9406 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2015 | 7850 | 0.010 |
Why?
|
Functional Laterality | 1 | 2004 | 2253 | 0.010 |
Why?
|
Longitudinal Studies | 2 | 2007 | 14494 | 0.010 |
Why?
|
Viral Regulatory and Accessory Proteins | 1 | 1997 | 153 | 0.010 |
Why?
|
Nitric Oxide Synthase Type II | 1 | 1998 | 514 | 0.010 |
Why?
|
Vascular Endothelial Growth Factors | 1 | 1998 | 748 | 0.010 |
Why?
|
Sexual Behavior | 1 | 2006 | 2086 | 0.010 |
Why?
|
North America | 1 | 2000 | 1284 | 0.010 |
Why?
|
Survival Rate | 1 | 2010 | 12810 | 0.010 |
Why?
|
Enzyme Induction | 1 | 1996 | 452 | 0.010 |
Why?
|
Universal Precautions | 1 | 1995 | 34 | 0.010 |
Why?
|
Specialization | 1 | 2000 | 778 | 0.010 |
Why?
|
Health Status | 1 | 2008 | 4082 | 0.010 |
Why?
|
Neoplasm Transplantation | 1 | 1998 | 2014 | 0.010 |
Why?
|
Patient Isolation | 1 | 1995 | 100 | 0.010 |
Why?
|
Electroconvulsive Therapy | 1 | 1979 | 502 | 0.010 |
Why?
|
Animals | 4 | 2019 | 167960 | 0.010 |
Why?
|
Europe | 1 | 2000 | 3441 | 0.010 |
Why?
|
Models, Statistical | 1 | 2008 | 5075 | 0.010 |
Why?
|
Gene Transfer Techniques | 1 | 1998 | 1204 | 0.010 |
Why?
|
Genes, Tumor Suppressor | 1 | 1997 | 1055 | 0.010 |
Why?
|
Contact Tracing | 1 | 1995 | 268 | 0.010 |
Why?
|
Nerve Net | 1 | 2004 | 2261 | 0.010 |
Why?
|
Patient Admission | 1 | 2000 | 1385 | 0.010 |
Why?
|
Medicine | 1 | 2000 | 943 | 0.010 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 1996 | 1173 | 0.010 |
Why?
|
Cells, Cultured | 2 | 1997 | 18955 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2007 | 8950 | 0.010 |
Why?
|
Transplantation, Heterologous | 1 | 1998 | 2379 | 0.010 |
Why?
|
Body Mass Index | 1 | 2007 | 12914 | 0.010 |
Why?
|
Safety Management | 1 | 1995 | 760 | 0.010 |
Why?
|
Electroencephalography | 1 | 2004 | 6189 | 0.010 |
Why?
|
Down-Regulation | 1 | 1996 | 2913 | 0.000 |
Why?
|
Methylcholanthrene | 1 | 1988 | 31 | 0.000 |
Why?
|
Propane | 1 | 1988 | 12 | 0.000 |
Why?
|
Cholic Acid | 1 | 1988 | 31 | 0.000 |
Why?
|
NADPH-Ferrihemoprotein Reductase | 1 | 1988 | 30 | 0.000 |
Why?
|
NAD(P)H Dehydrogenase (Quinone) | 1 | 1988 | 53 | 0.000 |
Why?
|
Quinone Reductases | 1 | 1988 | 23 | 0.000 |
Why?
|
Neovascularization, Pathologic | 1 | 1998 | 2640 | 0.000 |
Why?
|
Carbon Tetrachloride | 1 | 1988 | 72 | 0.000 |
Why?
|
Colon | 1 | 1996 | 1788 | 0.000 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 1998 | 3484 | 0.000 |
Why?
|
Heart Rate | 1 | 1999 | 4180 | 0.000 |
Why?
|
Phenobarbital | 1 | 1988 | 189 | 0.000 |
Why?
|
Fibroblasts | 1 | 1997 | 4089 | 0.000 |
Why?
|
NADP | 1 | 1988 | 223 | 0.000 |
Why?
|
Antipsychotic Agents | 1 | 2000 | 3061 | 0.000 |
Why?
|
Rats, Inbred Strains | 1 | 1988 | 2094 | 0.000 |
Why?
|
Survival Analysis | 1 | 1999 | 10185 | 0.000 |
Why?
|
DNA Damage | 1 | 1996 | 2442 | 0.000 |
Why?
|
Multivariate Analysis | 1 | 1999 | 12159 | 0.000 |
Why?
|
Cytochrome P-450 Enzyme System | 1 | 1988 | 412 | 0.000 |
Why?
|
Protein Binding | 1 | 1997 | 9335 | 0.000 |
Why?
|
Repressor Proteins | 1 | 1996 | 2982 | 0.000 |
Why?
|
Cytosol | 1 | 1988 | 887 | 0.000 |
Why?
|
Proportional Hazards Models | 1 | 1999 | 12531 | 0.000 |
Why?
|
Promoter Regions, Genetic | 1 | 1996 | 5782 | 0.000 |
Why?
|
Disease Progression | 1 | 2000 | 13505 | 0.000 |
Why?
|
Blood Pressure | 1 | 1999 | 8525 | 0.000 |
Why?
|
United States | 1 | 2009 | 72448 | 0.000 |
Why?
|
Mice | 2 | 1998 | 81209 | 0.000 |
Why?
|
Pharmaceutical Preparations | 1 | 1988 | 1091 | 0.000 |
Why?
|
Gene Expression Regulation | 1 | 1997 | 11902 | 0.000 |
Why?
|
Rats | 1 | 1988 | 23709 | 0.000 |
Why?
|